Drug Combo Bests Sunitinib in RCC.
Sign Up to like & getrecommendations! Published in 2018 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-nb2018-023
Abstract: The phase III IMmotion151 trial found that the combination of atezolizumab and bevacizumab boosts progression-free survival compared with sunitinib in patients with advanced or metastatic renal cell carcinoma. The increase was 2.8 months in all… read more here.
Keywords: drug combo; sunitinib rcc; bests sunitinib; combo bests ... See more keywords